HES 130/0.4 (Voluven®) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. a prospective, randomized, open label, multicentre trial

European Journal of Anaesthesiology

Volumn 25, Issue 6, 2008, Pages 437-445

  Standl, T ^a,g   Lochbuehler, H ^b   Galli, C ^c   Reich, A ^d   Dietrich, G ^e   Hagemann, H ^f  

^a Academic Hospital Solingen   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f University Clinic   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Colloid; Human albumin; Hydroxyethyl starch; Infant; Newborn; Surgery

Indexed keywords

FENTANYL; HETASTARCH; HUMAN ALBUMIN; IMMUNOGLOBULIN; ISOFLURANE; KETAMINE; MIDAZOLAM; NITROUS OXIDE; ROCURONIUM; SEVOFLURANE; VECURONIUM;

ANEMIA; ANESTHESIA; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD CLOTTING; BLOOD GAS ANALYSIS; BLOOD VOLUME; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYELID EDEMA; FEMALE; FEVER; FLUID THERAPY; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MULTICENTER STUDY; NEWBORN; OSMOTIC PRESSURE; PAIN; PERIOPERATIVE PERIOD; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SIDE EFFECT; STATISTICAL ANALYSIS; URINE FLOW RATE;

ALBUMINS; ANALYSIS OF VARIANCE; BLOOD COAGULATION TESTS; BLOOD GAS ANALYSIS; FEMALE; HEMODYNAMICS; HETASTARCH; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; PILOT PROJECTS; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 43049142660     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021508003888     Document Type: Article

References (34)

1. Schwarz U. Intraoperative fluid therapy in infants and young children. Anaesthesist 1999; 48: 41-50.
2. Nadel S, De Munter C, Britto J, Levin M, Habib P. Albumin: saint or sinner. Arch Dis Child 1998; 79: 384-385.
3. Boldt J, Knothe C, Schindler H, Hammermann H, Dapper F, Hempelmann G. Volume replacement with hydroxyethyl starch solution in children. Br J Anaesth 1993; 70: 661-665.
4. Gregori L, Maring JA, MacAuley C et al. Partitioning of TSE infectivity during ethanol fractionation of human plasma. Biologicals 2004; 32: 1-10.
5. Hausdoerfer J, Hagemann H, Heine J. Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia. Anaesth Intensivther Notfallmed 1986; 21: 137-142.
6. Aly Hassan A, Lochbuehler H, Frey L, Messmer K. Global tissue oxygenation during normovolaemic haemodilution in young children. Paediatr Anaesth 1997; 7: 197-204.
7. So KW, Fok TF, Ng PC, Wong WW, Cheung KL. Randomized controlled trial of colloid or crystalloid in hypotensive preterm children. Arch Dis Child 1997; 76: F43-F46.
8. Stoddart PA, Rich P, Sury MR. A comparison of 4.5% humans albumin solution and Haemaccel in neonates undergoing major surgery. Paediatr Anaesth 1996; 6: 103-106.
9. Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200/0.5 in total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996; 83: 262-268.
10. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: frequency, risk factors, mechanisms. Ann Fr Anesth Reanim 1994; 13: 301-310.
11. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F. Tissue storage of 14C-labeled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 2003; 4: 331-338.
12. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-699.
13. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988; 28: 257-260.
14. Treib J, Haass A, Pindur G et al. Increased hemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch. Arzneim Forsch Drug Res 1997; 47: 18-22.
15. Haisch G, Boldt J, Krebs C, Kumle B. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001; 92: 565-571.
16. Jungheinrich C, Sauermann W, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery - a randomised, double-blind study. Drugs R D 2004; 5: 1-9.
17. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001; 93: 405-409.
18. Standl T, Burmeister MA, Schroeder F et al. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution. Anesth Analg 2003; 96: 936-943.
19. Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005; 100: 1773-1780.
20. Blumer JL. Off-label use of drugs in children. Pediatrics 1999; 104: 598-602.
21. Waitzinger J, Bepperling F, Pabst G, Opitz J, Müller M, Baron JF. Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6% and 10% solutions in healthy volunteers. Clin Drug Invest 1998; 16: 151-160.
22. Waitzinger J, Bepperling F, Pabst G et al. Hydroxyethyl starch (HES) [130/0.4], a new HES specification. Pharmacokinetics and safety after multiple infusions of 10% solution in healthy Volunteers. Drugs R D 2003; 4: 149-157.
23. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 2002; 95: 544-551.
24. Gallandat Huet RCG, Siemons AW, Baus D et al. A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47: 1207-1215.
25. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven®, a lower substituted novel hydroxyethyl starch (HES 130/00.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92: 855-862.
26. James MF, Latoo MY, Mythen MG et al. Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers. Anaesthesia 2004; 59: 738-742.
27. Gandhi S, Warltier D, Weiskopf R, Bepperling F, Baus D, Jungheinrich C. Volume substitution therapy with HES 130/0.4 (Voluven) versus HES 450/0.7 (hetastarch) during major orthopedic surgery. Crit Care 2005; 9(Suppl. 1): 206.
28. Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet 2003; 362: 1320-1323.
29. Shafiee MAS, Bohn D, Hoorn EJ, Halperin ML. How to select optimal maintenance intravenous fluid therapy. Q J Med 2003; 96: 601-610.
30. Liet JM, Bellouin AS, Boscher C, Lejus C, Rozé JC. Plasma volume expansion by medium molecular weight hydroxyethyl starch in neonates: a pilot study. Pediatr Crit Care Med 2003; 4: 305-307.
31. Paul M, Dueck M, Herrmann J, Holzki J. A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/ 0.5) vs. lactated Ringer's solution. Pediatric Anesth 2003; 13: 603-608.
32. Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung Ok K. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand 2006; 50: 108-111.
33. Wills BA, Nguyen MD, Ha TL et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353: 877-889.
34. Bjorksten B, Hattevig G, Kjellman B, Ahlstedt S, Richter W. Dextran-reactive antibodies in healthy infants and toddlers - relation to type of feeding. Int Arch Allergy Appl Immunol 1982; 69: 174-178.